KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.13%.

  • Pfizer's Return on Capital Employed rose 1300.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.1% for FY2024, which is 300.0% up from last year.
  • Per Pfizer's latest filing, its Return on Capital Employed stood at 0.13% for Q3 2025, which was up 1300.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Pfizer's Return on Capital Employed ranged from a high of 0.37% in Q4 2022 and a low of 0.17% during Q4 2023
  • Over the past 5 years, Pfizer's median Return on Capital Employed value was 0.12% (recorded in 2025), while the average stood at 0.1%.
  • In the last 5 years, Pfizer's Return on Capital Employed soared by 2100bps in 2021 and then plummeted by -4000bps in 2023.
  • Quarter analysis of 5 years shows Pfizer's Return on Capital Employed stood at 0.23% in 2021, then soared by 62bps to 0.37% in 2022, then tumbled by -146bps to 0.17% in 2023, then skyrocketed by 100bps to 0.0% in 2024, then soared by 31096bps to 0.13% in 2025.
  • Its Return on Capital Employed was 0.13% in Q3 2025, compared to 0.11% in Q2 2025 and 0.11% in Q1 2025.